IBS-D - Articles and news items

RedHill Biopharma enrols last patient in Phase II irritable bowel syndrome trial

Industry news / 26 April 2017 / Niamh Marriott, Junior Editor

RedHill Biopharma has enrolled the last patient in the Phase II study with Bekinda for the treatment of diarrhoea-predominant irritable bowel syndrome…

Allergen receives positive opinion for IBS drug

Industry news / 26 July 2016 / Niamh Louise Marriott, Digital Content Producer

Trubberzi is an oral medication taken to relieve the main symptoms of irritable bowel syndrome with diarrhoea (IBS-D) in adults…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+